Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 672

1.

Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from TRANSFORM study.

Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Hernandez Gutierrez MP, Marti AM, Bernhardt P, Pascual J.

Am J Transplant. 2019 Jun 1. doi: 10.1111/ajt.15480. [Epub ahead of print]

PMID:
31152476
2.

Temporal virus serological profiling of kidney graft recipients using VirScan.

Isnard P, Kula T, Avettand Fenoel V, Anglicheau D, Terzi F, Legendre C, Elledge SJ, Canaud G.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10899-10904. doi: 10.1073/pnas.1821166116. Epub 2019 May 13.

PMID:
31085644
3.

Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies.

Glotz D, Russ G, Rostaing L, Legendre C, Tufveson G, Chadban S, Grinyó J, Mamode N, Rigotti P, Couzi L, Büchler M, Sandrini S, Dain B, Garfield M, Ogawa M, Richard T, Marks WH; C10-002 Study Group.

Am J Transplant. 2019 Apr 23. doi: 10.1111/ajt.15397. [Epub ahead of print]

PMID:
31012541
4.

Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.

Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A, Halloran PF, Dragun D.

Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30173-5. doi: 10.1016/j.kint.2019.01.030. [Epub ahead of print]

PMID:
31005275
5.

Membranous Nephropathy Post-Transplantation: An Update of the Pathophysiology and Management.

Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV.

Transplantation. 2019 Apr 10. doi: 10.1097/TP.0000000000002758. [Epub ahead of print]

PMID:
30985736
6.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
7.

Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2019 Apr;568(7752):E6. doi: 10.1038/s41586-019-1109-3.

PMID:
30944482
8.

Management of Kaposi Sarcoma after Solid Organ Transplantation: a European Retrospective Study.

Delyon J, Rabate C, Euvrard S, Harwood CA, Proby C, Güleç AT, Seçkin D, Del Marmol V, Bouwes-Bavinck JN, Ferrándiz-Pulido C, Ocampo MA, Barete S, Legendre C, Francès C, Porcher R, Lebbe C; Skin Care in Organ Transplant Patients Europe (SCOPE) group.

J Am Acad Dermatol. 2019 Mar 19. pii: S0190-9622(19)30442-6. doi: 10.1016/j.jaad.2019.03.028. [Epub ahead of print]

PMID:
30902727
9.

Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.

Fontaine H, Alric L, Labreuche J, Legendre B, Louvet A, Antoine C, Legendre CM, Hazzan M, Kamar N, Dharancy S, Pol S, Duhamel A, Mathurin P.

J Hepatol. 2019 May;70(5):831-838. doi: 10.1016/j.jhep.2018.12.036. Epub 2019 Mar 14.

PMID:
30879789
10.

Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.

Aubert O, Higgins S, Bouatou Y, Yoo D, Raynaud M, Viglietti D, Rabant M, Hidalgo L, Glotz D, Legendre C, Delahousse M, Shah N, Sis B, Campbell P, Mengel M, Jouven X, Van Huyen JD, Lefaucheur C, Loupy A.

J Am Soc Nephrol. 2019 Apr;30(4):625-639. doi: 10.1681/ASN.2018070777. Epub 2019 Mar 14.

PMID:
30872323
11.

Dynamic predictions of long-term kidney graft failure: an information tool promoting patient-centred care.

Fournier MC, Foucher Y, Blanche P, Legendre C, Girerd S, Ladrière M, Morelon E, Buron F, Rostaing L, Kamar N, Mourad G, Garrigue V, Couvrat-Desvergnes G, Giral M, Dantan E; DIVAT Consortium.

Nephrol Dial Transplant. 2019 Mar 11. pii: gfz027. doi: 10.1093/ndt/gfz027. [Epub ahead of print]

PMID:
30859193
12.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
13.

Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Jacquemont L, Hourmant M, Del Bello A, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Maillard N, Dubourg L, Lemoine S, Garrouste C, Pottel H, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2019 Apr;95(4):896-904. doi: 10.1016/j.kint.2018.11.029. Epub 2019 Feb 26.

PMID:
30819555
14.

GFR Assessment of Living Kidney Donors Candidates.

Gaillard F, Legendre C, White CA.

Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002620. [Epub ahead of print]

PMID:
30801521
15.

The Case | Posttransplant upper limb inflammatory nodules.

Brunel M, Leclerc-Mercier S, Barnier JP, Bille E, Sberro-Soussan R, Legendre C, Scemla A.

Kidney Int. 2019 Mar;95(3):721-722. doi: 10.1016/j.kint.2018.10.012. No abstract available.

PMID:
30784666
16.

Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.

Bouatou Y, Viglietti D, Pievani D, Louis K, Duong Van Huyen JP, Rabant M, Aubert O, Taupin JL, Glotz D, Legendre C, Loupy A, Lefaucheur C.

Am J Transplant. 2019 Feb 12. doi: 10.1111/ajt.15299. [Epub ahead of print]

PMID:
30748089
17.

Conversion from calcineurin inhibitors to belatacept in HLA- sensitized kidney-transplant recipients with low-level donor specific antibodies.

Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R.

Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002592. [Epub ahead of print]

PMID:
30720681
18.

Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.

Tew BY, Legendre C, Gooden GC, Johnson KN, Martinez RA, Kiefer J, Bernstein M, Glen J, Butry L, Hinek A, Toms SA, Salhia B.

Oncogene. 2019 May;38(21):4002-4014. doi: 10.1038/s41388-019-0680-2. Epub 2019 Jan 30.

PMID:
30700832
19.

Baseline graft status is a critical predictor of kidney graft failure after diarrhoea.

Devresse A, Morin L, Aulagnon F, Taupin JL, Scemla A, Lanternier F, Aubert O, Aidoud AA, Lebreton X, Sberro-Soussan R, Snanoudj R, Amrouche L, Tinel C, Martinez F, Bererhi L, Anglicheau D, Lortholary O, Legendre C, Avettand-Fenoel V, Zuber J.

Nephrol Dial Transplant. 2019 Jan 3. doi: 10.1093/ndt/gfy386. [Epub ahead of print]

PMID:
30608553
20.

No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.

Devresse A, Tinel C, Vermorel A, Snanoudj R, Morin L, Avettand-Fenoel V, Amrouche L, Scemla A, Zuber J, Legendre C, Rabant M, Anglicheau D.

Transpl Int. 2019 May;32(5):481-492. doi: 10.1111/tri.13392. Epub 2019 Jan 11.

PMID:
30565748
21.

mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.

Johnson SC, Martinez F, Bitto A, Gonzalez B, Tazaerslan C, Cohen C, Delaval L, Timsit J, Knebelmann B, Terzi F, Mahal T, Zhu Y, Morgan PG, Sedensky MM, Kaeberlein M, Legendre C, Suh Y, Canaud G.

Kidney Int. 2019 Feb;95(2):455-466. doi: 10.1016/j.kint.2018.08.038. Epub 2018 Nov 22.

PMID:
30471880
22.

Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study.

Foucher Y, Le Borgne F, Legendre C, Morelon E, Buron F, Girerd S, Ladrière M, Mourad G, Garrigue V, Glotz D, Lefaucheur C, Cassuto E, Albano L, Giral M.

Nephrol Dial Transplant. 2019 May 1;34(5):886-891. doi: 10.1093/ndt/gfy317.

PMID:
30325453
23.

Comparison of Postdonation Kidney Function Between Caucasian Donors and Low-risk APOL1 Genotype Living Kidney Donors of African Ancestry.

Gaillard F, Gribouval O, Courbebaisse M, Fournier C, Antignac C, Legendre C, Servais A.

Transplantation. 2018 Nov;102(11):e462-e463. doi: 10.1097/TP.0000000000002405. No abstract available.

PMID:
30247453
24.

Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.

Hendricks WPD, Zismann V, Sivaprakasam K, Legendre C, Poorman K, Tembe W, Perdigones N, Kiefer J, Liang W, DeLuca V, Stark M, Ruhe A, Froman R, Duesbery NS, Washington M, Aldrich J, Neff MW, Huentelman MJ, Hayward N, Brown K, Thamm D, Post G, Khanna C, Davis B, Breen M, Sekulic A, Trent JM.

PLoS Genet. 2018 Sep 6;14(9):e1007589. doi: 10.1371/journal.pgen.1007589. eCollection 2018 Sep.

25.

The age-calibrated measured glomerular filtration rate improves living kidney donation selection process.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Del Bello A, Girerd S, Kessler M, Flamant M, Vidal-Petiot E, Peraldi MN, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Caillard S, Gatault P, Büchler M, Maillard N, Dubourg L, Roquet O, Garrouste C, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2018 Sep;94(3):616-624. doi: 10.1016/j.kint.2018.05.016.

PMID:
30143068
26.

Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Legendre C, Viebahn R, Fehrman-Ekholm I, Masnou N, Berenguer M, Potena L, Wennberg L, O'Grady J, Epailly E, Diekmann F, Binet I, Schwenger V, Kuypers D, Guthoff M.

Transplantation. 2018 Sep;102(9S Suppl 1):S1-S14. doi: 10.1097/TP.0000000000002316. No abstract available.

PMID:
30113932
27.

Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study.

Couvrat-Desvergnes G, Foucher Y, Le Borgne F, Dion A, Mourad G, Garrigue V, Legendre C, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Giral M, Dantan E.

Nephrol Dial Transplant. 2019 Apr 1;34(4):703-711. doi: 10.1093/ndt/gfy221.

PMID:
30060106
28.

Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 Jul 27;15(7):e1002637. doi: 10.1371/journal.pmed.1002637. eCollection 2018 Jul.

29.

Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.

Coemans M, Süsal C, Döhler B, Anglicheau D, Giral M, Bestard O, Legendre C, Emonds MP, Kuypers D, Molenberghs G, Verbeke G, Naesens M.

Kidney Int. 2018 Nov;94(5):964-973. doi: 10.1016/j.kint.2018.05.018. Epub 2018 Jul 24.

PMID:
30049474
30.

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes.

Gerhard GS, Legendre C, Still CD, Chu X, Petrick A, DiStefano JK.

J Endocr Soc. 2018 Jun 5;2(7):710-726. doi: 10.1210/js.2018-00122. eCollection 2018 Jul 1.

31.

Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13. Erratum in: Nature. 2019 Apr;568(7752):E6.

PMID:
29899452
32.

FSGS ACTH Gel: Part of the Answer?

Delville M, Canaud G, Legendre C.

Transplantation. 2019 Jan;103(1):15-16. doi: 10.1097/TP.0000000000002321. No abstract available.

PMID:
29894412
33.

Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.

Viglietti D, Bouatou Y, Kheav VD, Aubert O, Suberbielle-Boissel C, Glotz D, Legendre C, Taupin JL, Zeevi A, Loupy A, Lefaucheur C.

Kidney Int. 2018 Oct;94(4):773-787. doi: 10.1016/j.kint.2018.03.015. Epub 2018 May 22.

PMID:
29801667
34.

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 May 25;15(5):e1002572. doi: 10.1371/journal.pmed.1002572. eCollection 2018 May. Erratum in: PLoS Med. 2018 Jul 27;15(7):e1002637.

35.

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators.

J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11.

PMID:
29752413
36.

Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.

Teslow EA, Bao B, Dyson G, Legendre C, Mitrea C, Sakr W, Carpten JD, Powell I, Bollig-Fischer A.

Mol Oncol. 2018 Jun;12(7):1138-1152. doi: 10.1002/1878-0261.12316. Epub 2018 May 24.

37.

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation.

Mai HL, Treilhaud M, Ben-Arye SL, Yu H, Perreault H, Ang E, Trébern-Launay K, Laurent J, Malard-Castagnet S, Cesbron A, Nguyen TVH, Brouard S, Rostaing L, Houssel-Debry P, Legendre C, Girerd S, Kessler M, Morelon E, Sicard A, Garrigue V, Karam G, Chen X, Giral M, Padler-Karavani V, Soulillou JP.

Transplant Direct. 2018 Mar 20;4(4):e357. doi: 10.1097/TXD.0000000000000772. eCollection 2018 Apr.

38.

[Identifying the specific causes of kidney allograft loss: A population-based study].

Lohéac C, Aubert O, Loupy A, Legendre C.

Nephrol Ther. 2018 Apr;14 Suppl 1:S39-S50. doi: 10.1016/j.nephro.2018.02.018. French.

PMID:
29606262
39.

Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival.

See SB, Aubert O, Loupy A, Veras Y, Lebreton X, Gao B, Legendre C, Anglicheau D, Zorn E.

J Am Soc Nephrol. 2018 Jun;29(6):1761-1770. doi: 10.1681/ASN.2017111157. Epub 2018 Mar 30.

40.

Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study.

Darres A, Ulloa C, Brakemeier S, Garrouste C, Bestard O, Del Bello A, Sberro Soussan R, Dürr M, Budde K, Legendre C, Kamar N.

Transplantation. 2018 Sep;102(9):1545-1552. doi: 10.1097/TP.0000000000002192.

PMID:
29570163
41.

Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study.

Mallet V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, Deau B, Portal A, Chaix ML, Hauser L, Beylouné A, Mercadier A, Izopet J, Legendre C, Pol S.

Transplantation. 2018 Aug;102(8):1351-1357. doi: 10.1097/TP.0000000000002185.

PMID:
29561324
42.

Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate.

Boubia B, Poupardin O, Barth M, Binet J, Peralba P, Mounier L, Jacquier E, Gauthier E, Lepais V, Chatar M, Ferry S, Thourigny A, Guillier F, Llacer J, Amaudrut J, Dodey P, Lacombe O, Masson P, Montalbetti C, Wettstein G, Luccarini JM, Legendre C, Junien JL, Broqua P.

J Med Chem. 2018 Mar 22;61(6):2246-2265. doi: 10.1021/acs.jmedchem.7b01285. Epub 2018 Feb 27.

PMID:
29446942
43.

Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus.

Devresse A, Leruez-Ville M, Scemla A, Avettand-Fenoel V, Morin L, Lebreton X, Tinel C, Amrouche L, Lamhaut L, Timsit MO, Zuber J, Legendre C, Anglicheau D.

Transpl Infect Dis. 2018 Apr;20(2):e12846. doi: 10.1111/tid.12846. Epub 2018 Feb 21.

PMID:
29360195
44.

Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donors.

Querard AH, Le Borgne F, Dion A, Giral M, Mourad G, Garrigue V, Rostaing L, Kamar N, Loupy A, Legendre C, Morelon E, Buron F, Foucher Y, Dantan E.

Am J Transplant. 2018 May;18(5):1151-1157. doi: 10.1111/ajt.14651. Epub 2018 Feb 8.

45.

The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.

Bienaimé F, Dechartres A, Anglicheau D, Sabbah L, Montgermont P, Friedlander G, Ravaud P, Legendre C, Prié D.

Kidney Int Rep. 2017 May 18;2(5):881-892. doi: 10.1016/j.ekir.2017.05.007. eCollection 2017 Sep.

46.

Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection.

Viglietti D, Loupy A, Aubert O, Bestard O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Jouven X, Delahousse M, Kamar N, Lefaucheur C.

J Am Soc Nephrol. 2018 Feb;29(2):606-619. doi: 10.1681/ASN.2017070749. Epub 2017 Dec 18.

47.

Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.

Girerd S, Girerd N, Duarte K, Giral M, Legendre C, Mourad G, Garrigue V, Morelon E, Buron F, Kamar N, Del Bello A, Ladrière M, Kessler M, Frimat L.

Transpl Int. 2018 Apr;31(4):408-423. doi: 10.1111/tri.13105. Epub 2017 Dec 20.

48.

Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.

Rabant M, Boullenger F, Gnemmi V, Pellé G, Glowacki F, Hertig A, Brocheriou I, Suberbielle C, Taupin JL, Anglicheau D, Legendre C, Duong Van Huyen JP, Buob D.

Am J Transplant. 2018 Apr;18(4):972-981. doi: 10.1111/ajt.14617. Epub 2018 Jan 12.

49.

Response to: "Renal allograft histology at 10 years after transplantation in the tacrolimus era: Evidence of pervasive chronic injury".

Snanoudj R, Legendre C.

Am J Transplant. 2018 May;18(5):1292. doi: 10.1111/ajt.14612. Epub 2017 Dec 28. No abstract available.

50.

Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.

Séhédic D, Chourpa I, Tétaud C, Griveau A, Loussouarn C, Avril S, Legendre C, Lepareur N, Wion D, Hindré F, Davodeau F, Garcion E.

Theranostics. 2017 Oct 12;7(18):4517-4536. doi: 10.7150/thno.19403. eCollection 2017.

Supplemental Content

Loading ...
Support Center